When the heart muscle fails, the entire system faces a structural crisis

Cardiomyopathy Overview - types (dilated, hypertrophic, restrictive), pathophysiology and treatment · 8:03 · Video: Armando Hasudungan · Watch at the source

In short: Cardiomyopathy isn't a single disease; it is a heterogeneous group of conditions where the heart muscle becomes structurally or electrically dysfunctional. From genetic inheritance to toxic exposure, these disorders weaken the heart's ability to pump, often leading to progressive heart failure and significant morbidity.

Cardiomyopathy is defined as an anatomic and pathologic diagnosis involving the heart's muscle or electrical system. While it often presents as progressive heart failure, the underlying mechanisms vary significantly. The American Heart Association (AHA) classifies these diseases based on whether they are primary—resulting from genetic, mixed, or acquired factors—or secondary, which stem from infiltrative, toxic, or inflammatory processes. The condition may be confined to the heart or represent part of a broader systemic disorder. Clinicians often use B-type natriuretic peptide levels and baseline serum chemistries to aid in diagnosis.

The four major types are distinct in their pathophysiology: dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathy. In these conditions, the heart may undergo inappropriate ventricular hypertrophy (thickening) or dilatation (stretching). While some types are rare or temporary and can improve over time, others are chronic. Because the heart is a central pump, these structural changes can lead to systemic issues, potentially causing cardiovascular death or lasting disability. Symptoms typically mirror those of general heart failure, such as orthopnea, cough, and paroxysmal nocturnal dyspnea. These issues can emerge even though the disease is often asymptomatic during its early stages.

Management focuses on symptom relief and slowing disease progression rather than a definitive cure. Treatment is highly individualized based on the specific type and severity of the condition. Common interventions include pharmacotherapy—such as blood pressure medicines, blood thinners, and antiarrhythmics—alongside lifestyle modifications like low-sodium diets and smoking cessation. In advanced cases, medical technology provides critical support through implantable cardioverter-defibrillators, cardiac resynchronization therapy, or even heart transplantation. Specific surgical options for severe cases include septal myectomy or alcohol septal ablation. Patients are also encouraged to prioritize adequate sleep and stress reduction as part of their daily routine.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-cardiomyopathy-overview-types-dilated-hypertrophic-restricti.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…